Your cardiologist is part of the decision
For a man with heart disease, testosterone therapy is a shared decision between you, the men’s health provider and the cardiologist who manages your heart. Your cardiologist knows details a hormone evaluation cannot see: the state of your stents or bypass grafts, your heart rhythm history, how well your heart pumps and which medicines are working. Their input shapes whether treatment is reasonable and how it should be monitored.
Some heart situations rule testosterone out for now. The Endocrine Society guideline recommends against starting testosterone in men with uncontrolled heart failure, and it lists a heart attack or stroke within the last 6 months as a reason to wait. Blood pressure that is not yet controlled also needs attention first, since testosterone can raise it.
Medicines matter too. If you take nitrates for chest pain, ED medicines are off the table, which our page on men who take nitrates explains. If you are on several blood pressure medicines, our page on men on blood pressure medicines covers how those fit with hormone and ED care.
Waiting after a heart attack or stroke
After a heart attack or stroke, testosterone waits until your heart has had time to stabilize. The two main guidelines frame the wait slightly differently:
| Guideline | What it says about timing |
|---|---|
| Endocrine Society | Do not start testosterone within 6 months of a heart attack or stroke |
| American Urological Association | Do not start testosterone for 3 to 6 months after a cardiovascular event |
The AUA guideline also tells clinicians to explain that it cannot be stated definitively whether testosterone therapy increases or decreases cardiovascular risk. In practice, that window is a chance to finish cardiac rehab, settle on heart medicines and confirm that low testosterone is real rather than a temporary effect of illness. Testosterone often dips during and after a serious illness, so labs drawn in the hospital or soon after are rarely the ones to rely on.
What the TRAVERSE trial found
TRAVERSE is the largest trial of testosterone safety in men with heart risk, and its results are mixed in a way worth understanding. The study in the New England Journal of Medicine enrolled 5,246 men aged 45 to 80 with existing heart disease or a high risk of it, plus low testosterone and symptoms. They used testosterone gel or a placebo gel and were followed for an average of 33 months.
The main result was reassuring. A heart attack, stroke or cardiac death occurred in 7.0% of men on testosterone and 7.3% on placebo, a difference small enough that testosterone met the trial’s test for not increasing that risk. But some other problems were more common on testosterone: atrial fibrillation, acute kidney injury and pulmonary embolism. The Endocrine Society’s 2026 statement describes the pulmonary embolism finding as roughly a 50% relative increase, which matters most for men covered on our page about TRT after a blood clot.
The trial also has limits worth naming. Every man used a daily gel adjusted to keep testosterone in a normal range, so the results do not automatically carry over to injections or pellets, which produce different patterns of levels. Follow-up lasted around three years, not decades. And the men were selected and monitored carefully, which is the standard any real-world plan should match.
Those results changed the labels. In 2025 the FDA required class-wide changes that removed boxed-warning language about adverse cardiovascular outcomes, added the TRAVERSE findings and added blood pressure warnings to all testosterone products. Our articles on the TRAVERSE trial and on whether TRT can cause atrial fibrillation go into more detail.
Tighter hematocrit and blood pressure checks
Monitoring for a man with heart disease is closer than for a healthy man, because the side effects that matter most land on the heart and blood vessels. Testosterone raises red blood cell production, and thicker blood is the last thing a narrowed artery needs. The 2018 Endocrine Society guideline advises stopping testosterone if hematocrit goes above 54% until it falls to a safe level. For a man with coronary disease, providers aim to catch a rising trend well before that point.
| What is checked | Why it matters with heart disease |
|---|---|
| Hematocrit | Rising red cell levels thicken the blood |
| Blood pressure at every visit | Testosterone labels now warn it can increase blood pressure |
| Heart rhythm symptoms | Atrial fibrillation was more common on testosterone in TRAVERSE |
| Kidney function | Acute kidney injury was more common on testosterone in TRAVERSE |
| Leg swelling and breathlessness | Fluid retention and clots both need prompt review |
Format choice can help as well. Your provider may favor a format and dose that keeps levels steady rather than producing high peaks. Our page on the hematocrit blood test explains the number in plain terms.
Symptoms that need 911, not a follow-up visit
Some symptoms cannot wait for a clinic appointment, whether or not you are on testosterone. Call 911 or go to the nearest ER for:
- Chest pain, pressure or tightness, especially with sweating or nausea
- Sudden shortness of breath or coughing up blood
- Face drooping, arm weakness or slurred speech
- A racing or irregular heartbeat with dizziness or fainting
- Sudden swelling and pain in one leg
None of these should be handled by changing a dose or waiting for the next lab draw.
Questions to bring to your cardiologist
- Is my heart stable enough for testosterone to be considered, and when?
- Does my rhythm history make the atrial fibrillation finding more relevant to me?
- Which of my medicines would interact with testosterone or ED treatment?
- What hematocrit and blood pressure targets would you want the clinic to work toward?
- Would you like copies of my hormone labs?
How Ultimate Male works alongside your cardiology care
At Ultimate Male, a man with heart disease starts with the free phone call and a full review of his cardiac history before testosterone is discussed. Labs are drawn on site at San Gabriel or Downey, and your consultation with a PA-C or MD covers symptoms, labs, heart medicines and the timing of any recent events. The provider will ask for your cardiologist’s input and can send results directly to them.
If the timing is not right, the plan may focus first on other causes of fatigue or on erectile symptoms; our page on ED after a heart attack covers that path. Read more about how testosterone therapy is monitored at the clinic.
